References
- Pereira SP, Oldfield L, Ney A, Hart PA, Keane MG, Pandol SJ, et al. Early detection of pancreatic cancer. Lancet Gastroenterol Hepatol 2020;5:698-710 https://doi.org/10.1016/S2468-1253(19)30416-9
- Klatte DCF, Boekestijn B, Wasser MNJM, Feshtali Shahbazi S, Ibrahim IS, Mieog JSD, et al. Pancreatic cancer surveillance in carriers of a germline CDKN2A pathogenic variant: yield and outcomes of a 20-year prospective follow-up. J Clin Oncol 2022;40:3267-3277 https://doi.org/10.1200/JCO.22.00194
- Dbouk M, Katona BW, Brand RE, Chak A, Syngal S, Farrell JJ, et al. The multicenter cancer of pancreas screening study: impact on stage and survival. J Clin Oncol 2022;40:3257-3266 https://doi.org/10.1200/JCO.22.00298
- Miller FH, Lopes Vendrami C, Recht HS, Wood CG, Mittal P, Keswani RN, et al. Pancreatic cystic lesions and malignancy: assessment, guidelines, and the field defect. Radiographics 2022;42:87-105 https://doi.org/10.1148/rg.210056
- Surci N, Marchegiani G, Andrianello S, Pollini T, Muhlbacher J, Jomrich G, et al. The faith of non-surveilled pancreatic cysts: a bicentric retrospective study. Eur J Surg Oncol 2022;48:89-94 https://doi.org/10.1016/j.ejso.2021.06.007
- Balduzzi A, Marchegiani G, Pollini T, Biancotto M, Caravati A, Stigliani E, et al. Systematic review and meta-analysis of observational studies on BD-IPMNS progression to malignancy. Pancreatology 2021;21:1135-1145 https://doi.org/10.1016/j.pan.2021.04.009
- Overbeek KA, Levink IJM, Koopmann BDM, Harinck F, Konings ICAW, Ausems MGEM, et al. Long-term yield of pancreatic cancer surveillance in high-risk individuals. Gut 2022;71:1152-1160 https://doi.org/10.1136/gutjnl-2020-323611
- Ardeshna DR, Rangwani S, Cao T, Pawlik TM, Stanich PP, Krishna SG. Intraductal papillary mucinous neoplasms in hereditary cancer syndromes. Biomedicines 2022;10:1475
- Kulkarni NM, Mannelli L, Zins M, Bhosale PR, Arif-Tiwari H, Brook OR, et al. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals. Abdom Radiol (NY) 2020;45:729-742 https://doi.org/10.1007/s00261-019-02290-y
- Burk KS, Lo GC, Gee MS, Sahani DV. Imaging and screening of pancreatic cancer. Radiol Clin North Am 2017;55:1223-1234 https://doi.org/10.1016/j.rcl.2017.06.006
- Huang C, Simeone DM, Luk L, Hecht EM, Khatri G, Kambadakone A, et al. Standardization of MRI screening and reporting in individuals with elevated risk of pancreatic ductal adenocarcinoma: consensus statement of the PRECEDE consortium. AJR Am J Roentgenol 2022;219:903-914 https://doi.org/10.2214/AJR.22.27859
- Elbanna KY, Jang HJ, Kim TK. Imaging diagnosis and staging of pancreatic ductal adenocarcinoma: a comprehensive review. Insights Imaging 2020;11:58